PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

por Solomonidou, Nantia, Germanou, Daphnie, Strouthos, Iosif, Karagiannis, Efstratios, Farolfi, Andrea, Koerber, Stefan A., Debus, Juergen, Peeken, Jan C., Vogel, Marco E., Vrachimis, Alexis, Spohn, Simon K. B., Shelan, Mohamed, Aebersold, Daniel, Grosu, Anca-Ligia, Ceci, Francesco, Kroeze, Stephanie G. C., Guckenberger, Matthias, Fanti, Stefano, Belka, Claus, Hruby, George, Scharl, S., Wiegel, Thomas, Bartenstein, Peter, Henkenberens, Christoph, Emmett, Louise, Schmidt-Hegemann, Nina Sophie, Ferentinos, Konstantinos, Zamboglou, Constantinos
Publicado 2023

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer

por Zamboglou, Constantinos, Peeken, Jan C., Janbain, Ali, Katsahian, Sandrine, Strouthos, Iosif, Ferentinos, Konstantinos, Farolfi, Andrea, Koerber, Stefan A., Debus, Juergen, Vogel, Marco E., Combs, Stephanie E., Vrachimis, Alexis, Morganti, Alessio Giuseppe, Spohn, Simon K. B., Shelan, Mohamed, Aebersold, Daniel M., Grosu, Anca-Ligia, Ceci, Francesco, Henkenberens, Christoph, Kroeze, Stephanie G. C., Guckenberger, Matthias, Fanti, Stefano, Belka, Claus, Bartenstein, Peter, Hruby, George, Scharl, Sophia, Wiegel, Thomas, Emmett, Louise, Arnoux, Armelle, Schmidt-Hegemann, Nina-Sophie
Publicado 2023